LENZ Therapeutics (LENZ) Shares Outstanding (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Shares Outstanding data on file, last reported at $31.4 million in Q1 2026.

• Quarterly Shares Outstanding rose 13.87% year-over-year to $31.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.4 million (up 13.87% YoY) and the FY2025 annual result came in at $31.3 million, up 13.9% from the prior year.
• Shares Outstanding held at $31.4 million in Q1 2026 per LENZ's latest filing, from $31.3 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $58.2 million in Q2 2022 and bottomed at $1.9 million in Q4 2022.
• The 5-year median for Shares Outstanding is $27.5 million (2025), against an average of $29.0 million.
• The widest annual swing landed in 2022, when Shares Outstanding tumbled 96.64%; it then surged 1299.38% in 2024.
• Tracing LENZ's Shares Outstanding over 5 years: stood at $1.9 million in 2022, then rose by 1.15% to $2.0 million in 2023, then soared by 1297.33% to $27.5 million in 2024, then rose by 13.9% to $31.3 million in 2025, then advanced by 0.03% to $31.4 million in 2026.
• Per Business Quant, the three latest LENZ Shares Outstanding figures stand at $31.4 million (Q1 2026), $31.3 million (Q4 2025), and $28.6 million (Q3 2025).

Peer Comparison